News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Merck & Co.
NEWS
JOBS
IN THE PRESS
AWARDS
NEWS
Deals
Why Merck & Co.'s $95 Million Bet on cCAM Biotherapeutics in 2015 Did Not Pay Off
March 24, 2017
·
1 min read
Biotech Beach
Interview Insider: Tips on How to Get Hired From Merck & Co., Eli Lilly and Pfizer
March 17, 2017
·
5 min read
Drug Development
Pfizer And Merck & Co. Go For An Even Longer Throw Of The Javelin
March 10, 2017
·
1 min read
Business
Backed by Amazon and Big Names Like Bristol-Myers Squibb, Celgene and Merck & Co., Bay Area’s GRAIL Banks $900 Million
March 2, 2017
·
2 min read
Drug Development
Merck & Co., Eli Lilly Failure Puts Alzheimer’s Drug Development Spotlight on Rival Genentech
February 28, 2017
·
2 min read
Deals
Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy
February 24, 2017
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
June 22, 2026
·
7 min read
Press Releases
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
June 18, 2026
·
11 min read
Press Releases
Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages
June 17, 2026
·
11 min read
Press Releases
Nectin Therapeutics Reports Encouraging Phase 1 Results for NTX1088 in Combination with Keytruda® (pembrolizumab) at ASCO 2026
June 17, 2026
·
3 min read
Press Releases
Nivi, Inc. and MSD Collaborate to Expand HPV Disease Awareness and Cervical Cancer Prevention Through AI-Powered Platform
June 16, 2026
·
4 min read
Press Releases
Protillion Biosciences Announces Drug Discovery Collaboration with Merck
June 16, 2026
·
2 min read
Press Releases
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
June 14, 2026
·
19 min read
Press Releases
Merck Animal Health to Acquire TARGAN
June 11, 2026
·
5 min read
Press Releases
Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment
June 9, 2026
·
14 min read
Press Releases
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study
June 9, 2026
·
19 min read
